Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CRVO
Stock Latest News
Company Announcements
CervoMed Unveils Promising Phase 2b Trial Results
1d ago
8K
CRVO
Premium
Ratings
CervoMed’s Strategic Advancements in Clinical Trials Justify Buy Rating
1d ago
CRVO
Premium
The Fly
CervoMed announce new data from Phase 2b trial of RewinD-LB
1d ago
CRVO
Premium
The Fly
CervoMed appoints Matthew Winton as chief commercial, business officer
2d ago
CRVO
Premium
The Fly
CervoMed announces development program, benefits of neflamapimod
22d ago
CRVO
Premium
The Fly
H.C. Wainwright sets CervoMed price target into FDA clarity
1M ago
CRVO
Premium
The Fly
CervoMed price target raised to $31 from $15 at D. Boral Capital
2M ago
CRVO
Premium
Ratings
CervoMed’s Promising Developments and Financial Stability Drive Buy Rating with $20 Price Target
2M ago
CRVO
Premium
The Fly
CervoMed price target lowered to $16 from $20 at Roth Capital
2M ago
CRVO
Premium
Company Announcements
CervoMed Reports Promising Trial Results and Financial Update
2M ago
CRVO
Premium
The Fly
CervoMed reports Q2 EPS (70c), consensus (50c)
2M ago
CRVO
Premium
The Fly
CervoMed expects cash to fund operations into Q3 of 2026
2M ago
CRVO
Premium
Company Announcements
CervoMed Shares Business and Financial Updates Online
2M ago
8K
CRVO
Premium
The Fly
CervoMed price target raised to $27 from $21 at Canaccord
2M ago
CRVO
Premium
Ratings
CervoMed’s Promising Clinical Trial Data and Strategic Focus Boost Buy Rating and Price Target
2M ago
CRVO
Premium
Company Announcements
CervoMed Announces Positive Phase 2b Trial Results
2M ago
8K
CRVO
Premium
The Fly
CervoMed announces 32-week data from Extension phase of Phase 2b RewinD-LB
2M ago
CRVO
Premium
Company Announcements
CervoMed Stockholders Approve Key Proposals at Annual Meeting
4M ago
8K
CRVO
Premium
The Fly
CervoMed appoints Marco Verwijs as EVP, technical operations
4M ago
CRVO
Premium
Company Announcements
CervoMed Releases New Business and Financial Information
5M ago
8K
CRVO
Premium
Ratings
CervoMed’s Strategic Advancements and Market Opportunities Drive Buy Rating
5M ago
CRVO
Premium
Ratings
CervoMed’s Promising Future: Buy Rating Backed by Strong Pipeline and Financial Position
5M ago
CRVO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.